Sixty years of genome biology by Doolittle,  W. F. et al.
April 25th 2013 is the sixtieth anniversary of the 
infamous Watson and Crick Nature paper describing a 
model for the structure of DNA, published 25 April 1953: 
the now infamous ‘double helix’ [1]. Two accompanying 
papers from Rosalind Franklin, Maurice Wilkins and 
colleagues leant experimental support to the proposed 
structure in the form of X­ray diff raction data [2,3], as 
described elsewhere in this issue of Genome Biology [4]. 
Th e model was a landmark discovery in the history of 
modern science, and was notable for its cross­disciplinary 
importance: the question addressed was of immense 
biological importance, but it was physicists and chemists 
whose expertise and techniques were needed in order to 
arrive at an answer. One of these physicists, Ray Gosling, 
describes the unveiling of Watson and Crick’s double 
helix structure as a ‘eureka’ moment [4]: its simplicity and 
elegance were striking, and not only explained the X­ray 
diff raction data but also the mode of replication of life 
itself. It is rare for a scientifi c discovery to achieve such 
an iconic status, to pervade popular culture and the 
public consciousness, as well as to become an emblem of 
scientifi c inquiry  ­ as exemplifi ed by Genome Biology’s 
double helix­inspired logo. Although Avery had already 
shown DNA to be the genetic material [5], it took the 
convincing simplicity of Watson and Crick’s double helix 
for this notion to widely take hold, in place of theories 
favoring proteins. Th e discovery, therefore, had many 
important implications, and set the scene for future 
breakthroughs in the fi eld of genome biology.
To celebrate sixty years of such discoveries, we asked a 
jury composed of Genome Biology Editorial Board 
members to select key advances in the fi eld since 25 April 
1953. Th e brief was to choose a development that was 
either the most important or the most surprising, or that 
had the most personal impact, and to briefl y summarize 
why. A number of selections focused on technological 
advances ­ from restriction mapping through microarrays 
and high­throughput sequencing. Th ese technologies 
have clearly done much to inform our understanding of 
the biology of genomes. Th e most popular choice, how­
ever, was the discovery of introns. Much like the double 
helix, this discovery had something of the ‘X factor’ to it: 
biologists trained in the post­intron era may take the 
concept of gene fragmentation for granted, but at the 
time it was a truly radical and paradigm­shifting idea. 
Th e sense of surprise made a strong impression on those 
old enough to remember the discovery, and one of the 
groups involved went so far as to describe it as ‘amazing’ 
in the title of their paper [6].
‘Genes in pieces’: introns
Brenton Graveley
In 1977, Rich Roberts and Phil Sharp independently 
reported that genes can be interrupted by introns [6,7]. 
In my opinion, this is the biggest and most surprising 
discovery in genome biology since the structure of DNA 
was reported by Watson and Crick on 25 April 1953 [1]. 
Accordingly, Roberts and Sharp were awarded the Nobel 
Prize in Physiology or Medicine in 1993 for this dis­
covery. Th e existence of introns was entirely unexpected, 
and led to the subsequent discovery of the spliceosome, 
the macromolecular complex that removes introns. 
Alternative splicing, where exons can be joined together 
in diff erent patterns, is known to occur for nearly all 
human genes and plays important roles in both increas­
ing protein diversity and regulating biological processes. 
Th e implications of these fi ndings are very far reaching 
and it is now known that many human diseases are 
caused by mutations in the RNA sequences that direct 
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splicing, as well as in the proteins and RNAs that catalyze 
and regulate intron removal.
Jernej Ule
Walter Gilbert wrote an opinion article in 1978 beginning 
with the statement, ‘Our picture of the organisation of 
genes in higher organisms has recently undergone a revo­
lu tion’ [8]. In 1977, the Roberts and Sharp groups 
reported that viral mRNA molecules were shorter than 
their corresponding genes [6,7]. By 1978, a flurry of 
papers demonstrated that most genes in eukaryotic 
organ isms contain regions that are removed during the 
production of mRNAs. In his article, Gilbert proposed 
that we call these regions ‘introns’ (for intragenic regions).
Despite knowing the sequence of only a small number 
of genes in 1978, Gilbert was able to correctly predict 
that introns account for approximately ten times more 
genomic sequence than exons. But what was the function 
of this prevalent genomic feature? Since introns are 
removed from the nascent RNA, they marked a departure 
from early studies of genetic code. Introns did not fit 
easily into the simple, linear transfer of genetic infor ma­
tion from DNA to mRNA to protein. They required a 
different kind of thinking.
Gilbert predicted that parts of introns could in some 
cases become exons, a process that we now recognize as 
alternative splicing. Alternative splicing would increase 
protein diversity and, if its regulation was cell­type 
specific, it might even drive cellular differentiation. These 
hypotheses have since been validated by decades of 
research. Moreover, Gilbert envisioned that introns could 
be fertile ground for evolutionary tinkering, since 
mutations that modulate inclusion of exons could change 
the patterns of alternative splicing.
‘The extra material is scattered in the genome, to be 
called into action at any time... Evolution can seek new 
solutions without destroying the old.’ Here, Gilbert suggests 
that mutations can create novel mRNA isoforms without 
removing the previous isoforms. Thus, in spite of the 
apparent burden of extra genomic sequence, introns create 
a mechanism primed to explore evolutionary innovations. 
The idea that life has a vast in­built potential that remains 
to be realized had a strong impact on my thinking and 
research. This led us to the recent findings that the human 
genome contains a reservoir of transposable elements that 
can gradually evolve into exons by mutations that influence 
the competitive binding of multiple splicing factors [9]. 
Gilbert summarized the dual nature of introns as burden 
and blessing with typical elegance, ‘introns are both frozen 
remnants of history and the sites of future evolution.’
Steven Henikoff
I was just finishing up as a graduate student in 1977 when 
I first learned of the amazing discovery of split genes in 
adenovirus [6,7]. Shortly thereafter, rumors circulated 
that genes in pieces, or what Wally Gilbert referred to as 
exons and introns [8], are far more common than 
originally supposed, and in fact are the rule, rather than 
the exception. It was a thrill to realize that something 
that we all took for granted, from the dominant 
Escherichia coli paradigm of uninterrupted protein­
coding genes, does not hold in eukaryotic genomes. It is 
hard to think of another example in which a concept so 
fundamental as split genes and post­transcriptional 
splicing was not suspected to exist before its discovery. 
Wally began the debate over ‘why?’ [8] and others asked 
‘how?’ [10], but for me, the question was: what other 
surprises lay in store in the realm of eukaryotic gene 
organization? Thus began my interest in what later 
became referred to as genomics, and when I had my own 
lab, studying genes in pieces led to the surprising 
discovery of genes in pieces in genes in pieces [11].
Ford Doolittle
The discovery of spliceosomal introns in the genomes of 
eukaryotes [12­15] ranks very near the top of my list, in 
‘significance, surprise and (especially) personal impact’. I 
was at the time (1977) on sabbatical in the lab of Wally 
Gilbert and he, having just become aware of that amazing 
discovery, came up with ‘exon shuffling’ as an appealing 
raison­d’etre for introns’ existence [8]. Because I also 
knew of Carl Woese’s then very recent discovery of 
archaea and Carl’s inference therefrom that eukaryotes 
and prokaryotes might have diverged separately from a 
more primitive common ancestor [16], and because I did 
not believe that early eukaryotes would have taken on the 
burden of introneousness just because it might help them 
in the distant future, I cobbled together the theory that 
became known as ‘introns early’ [17].
Almost certainly that theory is false: it seems much 
more likely that spliceosomal introns are Group II introns 
gone to seed ­ fallen apart into ‘five easy pieces’ [18] and 
increasingly dependent on dozens of proteins, the 
accretion of which may have been largely through a 
neutral evolutionary ratchet. But ‘introns early’ had a 
great run, in large part thanks to Wally, and stimulated 
many to think more deeply about the evolution and 
functional significance of genome architecture. In parti­
cular, it forced us to accept that Dobzhansky’s rubric that 
‘nothing in biology makes sense except in the light of 
evolution’ is just as valid at the molecular level as the 
organismal. Genomes are much more than repositories 
of encoded information needed to make organisms, and 
we can be led astray if we adopt an overly functionalist/
adaptationist perspective. Genomicists and systems 
biologists are especially at risk of doing this, as the recent 
controversy surrounding the ENCODE project illus trates 
[19].
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Genomes become tangible: restriction mapping
George Weinstock
When I started graduate school in 1970 there were no 
restriction enzymes and agarose gels, let alone DNA 
sequences. Genetics was dominated by model organisms 
like E. coli, phage lambda, Saccharomyces cerevisiae and 
Drosophila melanogaster. It was based on linkage maps 
and recombination frequencies, complementation tests 
and cistrons, abstract concepts that only a geneticist 
could love and that probably made the field less accessible 
to other biologists. There were experiments relating 
genetic traits to physical locations on a chromosome, but 
these were relatively low resolution and had only limited 
impact on converting our view of the genome from the 
abstract concepts of genetic methodology to the bio­
chemical reality of DNA structure. Then, in the mid­
1970s, restriction enzymes [20,21] and agarose gels 
[22,23] began to change all of that. Suddenly it was 
possible to reduce the abstractions of linkage maps to 
detailed restriction maps (for example, [24]) with con­
crete physical distances instead of operational but 
obscure recombination frequencies. Being able to view 
genome structure in these tangible terms was a paradigm 
shift that made for a more comfortable way of describing 
genome structure for both the biologist and lay com­
munity. Of course, all of that led to great downstream 
advances ­ PCR, DNA sequencing, and much more. Now 
most biologists only think of genomes in palpable terms, 
never in the abstract genetic concepts, and probably 
would have a hard time imagining how you could do 
research without this. So to me, that DNA technology of 
the mid­1970s was the day genetics changed and we 
shifted from one era to the next.
A new regulatory paradigm: microRNA
John Rinn
The laws of genetics have never depended on what genes 
are made of chemically, and would hold true even if they 
were made of green cheese.
Ed Lewis
Genetic approaches are as fundamental to biology as 
math is to physics. One of the most bizarre, dogma­
shifting and inspiring genetic studies is exemplified in the 
article by Victor Ambros and colleagues entitled ‘The 
C. elegans heterochronic gene lin­4 encodes small RNAs 
with antisense complementarity to lin­14’ [25]. The study 
was published alongside related findings from Gary 
Ruvkun and colleagues [26].
As a testament to the strength of genetics, Ambros and 
colleagues went to heroic lengths to identify the function 
of the lin­4 gene, which Horvitz and Sulston had 
previously identified in a forward genetic screen for novel 
Caenorhabditis elegans cell­lineage mutants [27]. Dr 
Ambros’ lab started to investigate the mechanistic role of 
lin­4, using classic complementation to hone in on the 
gene product. They narrowed the locus down to a 3.2 kbp 
region, and then further refined it to a 693 bp region, that 
could complement or recover the lin­4 mutant phenotype 
of delayed development. Typically, this genetic resolution 
would have identified a protein­coding exon, leading to a 
more obvious explanation of the lin­4 gene product.
The first twist in this expedition into ‘noncodarnia’ was 
that the gene mapped not to a coding region, but within 
an intron of a protein­coding mRNA. Dogmatically, this 
region was already doomed to be labeled as junk, based 
on being encoded within an intron. Even worse, Northern 
blot and RNase protection analyses identified 61 nucleo­
tide and 22 nucleotide RNA species, which was smaller 
than any protein mRNA known at the time. Grounded in 
purely genetic observations, the authors continued to 
pursue the most heroic genetic exercise in this study: 
non­complementation. After surveying no less than 
20,000 mutants of the lin­4 bearing chromosome, only 
one was unable to complement the original lin­4 mutant. 
The source was a C­to­T transition within both the 61 
nucleotide and 22 nucleotide lin­4 RNA species. Thus, 
despite beginning with a most unorthodox genetic obser­
vation, the authors now had evidence that a mutation in 
this tiny RNA could indeed recapitulate the original lin­4 
mutant.
Taking these observations at face value, the authors put 
forward a model  ­ perhaps the only possible model  ­ in 
which this deviant 22 nucleotide or 61 nucleotide RNA 
hybridizes to the 3’ UTR of the lin­14 gene, and in doing 
so serves as a negative inhibitor. The inhibition of lin­14 
would explain the original observation of delayed 
development in lin­4 mutants. The unquestionable 
genetics underlying the interplay of lin­4 and lin­14 led, 
ten years ahead of its time, to a model that has become 
dogma. We now know, of course, that the authors had 
dis covered a whole new form of gene regulation, wide­
spread in nature, mediated by what Ambros and others 
[28­30] eventually christened microRNAs, or miRNAs. 
The visionary discussion section of Ambros and colleagues’ 
lin­4 article simply raises intellectual goosebumps.
The authors never deviated from the inherent truths of 
genetic observation, no matter how odd the underlying 
gene product. Despite having discovered this abstruse 
gene product, which in its day smelled something like 
green cheese, the genetic basis and implications were to 
them clear, correct and prophetic.
The original ‘data explosion’: microarrays
Alicia Oshlack
Ten years ago, I had no real concept of DNA. Genes, in 
my limited understanding, were passed down to you by 
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your parents but I had not made any clear connection 
between genes and DNA. My awareness was focused on 
the outer reaches of the universe and contemplating how 
gases revolve around black holes in the centers of 
quasars: my PhD topic. Had it not been for the discovery 
of microarrays, I may never have had the opportunity to 
turn my scientific career on its head and begin training in 
bioinformatics. The first expression microarrays were 
published in 1995 by Pat Brown’s group at Stanford [31], 
and by 2003 hundreds of discoveries were being made 
using the many different versions of this technology. The 
invention of microarrays produced a data explosion 
(although perhaps not as phenomenal as the one we are 
currently experiencing) and with this came a need for 
quantitative scientists to develop analysis methodology 
and interpretation of data. I was fortunate enough to 
have been given an opportunity to join the bioinformatics 
division of two pioneers in the field of microarray 
analysis, Gordon Smyth and Terry Speed. I consider the 
first couple of years of the job akin to a second PhD, in 
which my primary focus was methodology development 
for the analysis of microarray data. If it had not been for 
the invention of expression microarrays, my career may 
have ended up light years away from what I now believe 
to be the most interesting job in the world.
Unlocking ‘genetic messages’: sequencing 
technologies
Michael Schatz
The most significant development in genome biology 
since 25 April 1953 has been the rise of large­scale DNA 
sequencing, pioneered by Fred Sanger in 1977 [32], and 
refined over the last several decades in first, second, and 
now third generation automated sequencing techno lo­
gies. Determining the structure of DNA in 1953 was 
incredibly significant for determining the molecular 
framework for so many aspects of biology, including the 
frameworks for replication, transcription, inheritance, 
mutation and evolution, to name but a few. However, 
determining the structure of DNA is analogous to 
determining the structure of a piece of paper, void of any 
literature or mathematics written upon it. Now, with the 
rise of high­throughput sequencing, we have the capa­
bility to read the genetic messages written on those 
molecular pages. This capability has unlocked not only 
the human genome but also those of thousands of other 
species, revealing their genes, regulatory sequences and 
overall structures, which has in turn led to many 
important advances in biology and medicine. The next 
frontier in genome biology is to apply these technologies, 
and the related molecular assays empowered by DNA 
sequencing, over large populations of species, individuals 
and cells to compare, model and predict how these 
systems behave.
‘Sequence is power’: the human and mouse 
genome projects
Chris Ponting
To me, one important moment in genomics was in 2002 
when we could measure the human genome against an 
evolutionary yardstick, the mouse genome. Jim Kent of 
UCSC produced a wonderful visual guide (Figure 25a in 
[33]) to the most important features of mammalian 
genes. By collapsing levels of sequence conservation 
between thousands of mouse and human orthologs into 
one metagene, he showed how, from a common sequence 
over 90  million years ago, mutation has etched away 
intronic sequence whilst selection has greatly preserved 
the exons, particularly toward their boundaries. For me, 
Jim’s analysis was important in illustrating so very clearly 
how evolutionarily dynamic are our genes and genomes.
Mark Gerstein
I think the most significant advance in genomics since 
the unraveling of the double helical structure in 1953 has 
been the sequencing of the first personal genome, that of 
Craig Venter. The sequencing of a personal genome, not a 
reference or anonymous genome, links genomics to 
people and transforms the field from an abstract science 
of molecules to something very personal and connected 
to humankind. When we look back on 1953 from 2053, 
we will realize that the personal genome is what really 
brought DNA to the masses.
Peter Fraser
I suppose the most important ‘happening’ in genome 
biology since 1953 would have to be the human and 
mouse genome projects [33,34]. Prior to the completed 
sequences, these genomes were a seemingly infinite 
mystery. Individual investigators clung onto and pored 
over a few hard­fought kilobases of DNA sequence 
around their genes of interest. Going much beyond this 
in a time when sequences were still determined on gels 
was akin to interstellar travel. The genome projects 
essen tially turned each genome into a global village of 
finite proportions that is now rapidly filling with features. 
Though the genome projects themselves are not really a 
discovery, they have made possible countless other 
discoveries. I have decided to focus on one of these 
smaller discoveries, important in its time, but one of 
more personal significance. It serves as an excellent 
example of the many discoveries that the genome projects 
revolutionized. The discovery was of the properties of the 
beta­globin dominant control region, also called the 
locus activating region and later named by committee as 
the locus control region. This was a region about 
50  kilobases upstream of the beta­globin gene that was 
known to have profound effects on globin gene expres­
sion [35]. The element was in the dark area of the genome 
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in which no sequence existed, far away from the relative 
light of the gene­local kilobase or so of sequences 
flanking the globin genes. Instead of sequence, only pain­
stakingly determined restriction maps existed for this 
distant region. After discovery of its function, the focus 
switched to how such a long­range element could affect 
gene expression over such a distance. The debates were 
lively, passionate, some would say fierce, and this not only 
energized the field but, finally, 15  years later, led to 
experiments that provided evidence for a physical inter­
action­based mechanism, via long­range folding or 
‘looping’ of chromatin [36]. During this time, the various 
genome projects were gradually increasing the amount of 
genomic sequences available. Soon it was realized that 
many genes were controlled by long­range elements, 
some up to a megabase away, and nowadays it appears 
that most, if not all, genes may be controlled by many 
such elements [37]. But it didn’t stop there; built on the 
foundation of the complete genome sequence and fuelled 
by advanced high­throughput sequencing technologies, 
the folding of these individual loops into chromosomes, 
together with the way chromosomes are arranged and 
interact in the nucleus, is increasingly being appreciated 
as an important contributing factor to the control of 
many genome functions [38,39]. So, although the monu­
mental genome projects are the antithesis of the elegance 
of the Watson and Crick model, they must be seen as 
equally significant because of their present and future 
impacts. Sequence may not be knowledge, but it is power.
Retelling the human story: analysis of ancient and 
historical DNA
Detlef Weigel
‘What has been the most surprising discovery in the field 
of genome biology for you?’ In hindsight, it appears that 
many applications of high­throughput sequencing, in 
which I include automated Sanger sequencing, have long 
been obvious. Certainly, being able to read entire 
genomes was in principle already thinkable when I was in 
college in the early 1980s. What I believe would have 
been very difficult to imagine is the ability to study 
genomes from organisms that have been dead for 
thousands or even tens of thousands of years. The vision 
that my Max Planck colleague Svante Pääbo has had in 
this regard, and the dogged manner with which he has 
pursued the sequencing of ancient genomes, is absolutely 
remarkable. The work of Svante and his students has 
already revolutionized our understanding of human 
evolution in the distant past [40­48]. I believe it has 
similar potential for changing our knowledge of more 
recent history. A taste of what I am certain is an 
imminent avalanche of such studies has been provided by 
Bos and colleagues’ Nature study exploring the Black 
Death outbreak in medieval times [49].
The exception to the rule: lateral gene transfer
Curtis Huttenhower
I would suggest the discovery of horizontal gene transfer 
as one of the most remarkable in the history of genome 
biology. First, it arguably predates the discovery of the 
structure of DNA itself, having been implicated in 
Frederick Griffith’s transformation experiment in 1928 
[50]. As happens too often in biology, this simultaneously 
introduced both a rule (DNA as the agent of vertical 
genetic transmission) and its exception (lateral transfer). 
Second, this apparently straightforward concept was 
gradually shown to comprise a diversity of related 
biological mechanisms, perhaps culminating with Joshua 
Lederberg’s 1951 work on phage transduction [51] and 
1958 Nobel Prize for bacterial recombination. Even then, 
the extent and plasticity of lateral transfer were only 
emphasized later in the 1983 Nobel Prize to Barbara 
McClintock for the discovery of distinct mobile genetic 
elements ­ a discovery made decades earlier [52] but not 
widely accepted until the 1970s. The range of mechanisms 
by which transfer occurs has had implications as practical 
as driving the spread of antibiotic resistance and as far­
flung as casting doubt on the reconstruction of a 
universal tree of life. Third, horizontal transfer is notable 
in remaining an area of active research almost a century 
after its discovery. Its implications in ancient evolution or 
in eukaryotes are not yet clear. Likewise, its prevalence, 
dynamics, ecology, and functional consequences in 
micro bial communities continue to be explored. I hope 
that the 100th anniversary of DNA sees an even longer 
list of biological ramifications of horizontal gene transfer 
and continued discoveries in the field.
Abbreviations
bp, base pair; ENCODE, The Encyclopedia of DNA Elements; miRNA, microRNA; 
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